Response to Wernly, Datz, and Wernly.
Response to Wernly, Datz, and Wernly.
复制标题
对 Wernly、Datz 和 Wernly 的回应。
DOI:
10.1093/jnci/djab233
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Song,Mingyang
中科院分区:
文献类型:
--
作者:
Wang,Kai;Song,Mingyang
We appreciate the comments from Wernly et al.(1) on our cohort study in which we reported the benefit of colonoscopy screening according to individuals’ risk profiles. First, we agree that the effect size of the 8 risk factors constituting the risk profile in relation to colorectal cancer may vary and that using weighted scores can improve risk stratification. However, we chose the equal weighing approach to simplify 1) the interpretation of our findings (ie, 1-unit increase in the score represents an improvement in 1 risk factor); and 2) the public health message for potential clinical translation in the future. Also, a similar approach has been widely used by other groups in prior studies (2, 3). Second, we agree that some of the 8 risk factors may have biological interactions. However, the primary goal of our study is to test the clinical translational potential of using the risk factor data to improve cancer prevention rather than to best capture the biological effect of these factors. Finally, regarding the comment on accounting for sex, because our 2 cohorts are sex-specific (the Nurses’ Health Study includes women only and the Health Professionals Follow-up Study includes men only), all our analyses were stratified by cohort, and we additionally showed our main finding for women and men separately in the supplementary data of our original study (see the Supplementary Materials, available online). Our definition of tall stature is also sex specific. Nonetheless, we would like to thank Wernly et al.(1) for their comments.